9th Annual Biomarkers Congress

Cell Biology: Roche AG

Total Score People Score Events Score
28 24 22
Date Event Presentation Speakers
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Epitope characterization and crystal structure of GA101 provide insight into mechanism of action Christian Klein
Panel session Day 3: Bispecific antibodies and antibody-drug-conjugates Ulrich Brinkmann
Bispecific antibodies: CrossMAb and others Christian Klein
Bispecific digoxigenin-binding antibodies for targeted payload delivery Ulrich Brinkmann
March 7, 2011 Imaging in Cancer Drug Development Application of different imaging modalities in the drug development process Werner Scheuer,
June 23, 2010 Structure-Based Drug Design TABLE 5: Why Aren’t We Designing the Perfect Drug as Soon as We Have a Crystal Structure? Rama K. Kondru
Mutation Data Driven Binding Modes for CCR5 Antagonists: Applications in Structure Based Design Rama K. Kondru
Beyond Growing and Linking: Impact of Fragments on the Discovery of Kinas e Inhibitors Andreas Kuglstatter
August 24, 2009 Fifth Annual Optimizing Cell Culture Technologies Opening Keynote Presentation Ashley Hayes,
June 16, 2009 4th Annual Cell Based Assays Applying cellular label-free technologies in HTS and in 7TM receptor characterisation analysis Ralph J. Garippa
June 9, 2009 RNAi for Target Identification and Validation I. Surveying RNAi Opportunities: From Tools to Therapies Thomas Singer
June 3, 2009 Inaugural Drug Induced Liver Injury In vivo and in vitro prediction of DILI using genomics Adrian Roth
February 23, 2009 Advances and Progress in Drug Design VIII SCREENING TECHNOLOGIES AND STRUCTURE BASED DESIGN Michael Hennig
January 28, 2009 Electronic Laboratory Notebooks SYSTEMS INTEGRATION : Integrating systems and streamlining the research process Michael Braxenthaler
January 27, 2009 4th Annual Aseptic Filling and Processing Case study 1 | Implementation of 9 isolators in highly active facilities for semi-solid and parenteral drug products: multiple purpose concept, decision criteria and main project phases. Dieter Roethlisberger
December 1, 2008 9th Annual Conference E U R OT I D E S 2008 Opportunities and challenges of developing peptide drugs in the pharmaceutical industry Waleed Danho,
November 11, 2008 3rd Annual European Post- Translational Modifications Novel high-throughput method for the analysis of Fc-glycosylation of therapeutic antibodies in cell culture supernatants Dietmar Reusch
March 25, 2008 Molecular Diagnostics Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
Organizational, Strategic and Technical Considerations for Creating Clinically Differentiated Medicines and Companion Diagnostics: Successes vs. Failures, What Did We Learn? Tim M. Jaeger
March 25, 2008 R&D Risk Mitigation Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
March 25, 2008 Preclinical Development From Publication to Practice: Interlaboratory Validation of Microarray and QPCR-based Signatures for Predicting Carcinogenicity in the Rat Mark Fielden
February 19, 2008 Cancer Genomics and Epigenomics High Throughput Genome, Epigenome, and Cell Biology Approaches (Technology) Jeffrey A. Jeddeloh
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) TECHnology Platform EXPO (08:25-12:00) Michael Egholm
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Michael Egholm
TECHnology Platform EXPO: Why Length Matters in Next Generation Sequencing (08:35-09:20) Michael Egholm
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies: RNAi Screening to Identify and Validate Therapeutic Targets in Metabolic Diseases (08:40-09:10) John Reidhaar-Olson
In vitro RNAi Screening Strategies (08:30-10:40) John Reidhaar-Olson
In vitro RNAi Screening Strategies: Chairperson’s Remarks (08:30-08:40) John Reidhaar-Olson
Roundtable Discussion Topic: In vitro RNAi Screening (07:30-08:30) John Reidhaar-Olson
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) TECHnology Platform EXPO (08:25-12:00) Michael Egholm
TECHnology Platform EXPO: Why Length Matters in Next Generation Sequencing (08:35-09:20) Michael Egholm
Roundtable Discussion: Challenges and Opportunities - Where are We Now? (11:20-12:00) Michael Egholm
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Rebecca A. Taub
SCREENING AGAINST MULTIPLE TARGETS: Featured Presentation - Is Repositioning a Viable Option for Creating Differentiated Medicines? (13:40-14:15) Rebecca A. Taub
PROFILING TO OPTIMIZE EFFICACY (08:30-14:00) Wolfgang Guba
PROFILING TO OPTIMIZE EFFICACY: Case Study - Chemogenomic Strategies for GPCR Hit Finding (11:15-11:45) Wolfgang Guba
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS: Featured Presentation - Is Repositioning a Viable Option for Creating Differentiated Medicines? (13:40-14:15) Rebecca A. Taub
SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Rebecca A. Taub
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY: Proteomic Analysis of Protein-Protein Interaction for Identification of Membrane Markers of Disease (11:30-12:00) Jinzhi Chen
Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY (08:30-16:00) Jinzhi Chen
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.